[Systemic effects of topically applied hydrocortisone 17-butyrate 21-propionate ointment--comparative studies with betamethasone 17-valerate and hydrocortisone 17-butyrate ointment (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001623:Betamethasone / Q000031:analogs & derivatives*; D001624:Betamethasone Valerate / Q000009:adverse effects*; D001786:Blood Glucose / Q000032:analysis; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004804:Eosinophils; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood*; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009823:Ointment Bases
D001786:Blood Glucose; D009823:Ointment Bases; C007975:hydrocortisone-17-butyrate; C033014:hydrocortisone 17-butyrate 21-propionate; D001623:Betamethasone; D001624:Betamethasone Valerate; D006854:Hydrocortisone